The Role of Maspin in Colorectal Carcinoma, an Immunohistochemical Study

Launched by ASSIUT UNIVERSITY · Apr 3, 2025

Keywords

ClinConnect Summary

This clinical trial is investigating the role of a protein called maspin in colorectal cancer, which is a common type of cancer that affects the colon. Researchers want to understand how maspin behaves in different parts of the cancer cells and how it might influence the cancer's growth and spread. They have found that maspin can either help prevent cancer from getting worse or, in some cases, make it more aggressive, depending on how it is expressed in the cells. By studying maspin, the goal is to learn more about its potential as a marker for predicting how well someone might do with colorectal cancer.

To participate in this study, patients need to have been diagnosed with colorectal cancer at any stage, and they should have tissue samples available for research. The trial is currently not recruiting participants yet, but it aims to include individuals of all genders, typically between the ages of 65 and 74. If you are interested in this study, you would need to meet the specific eligibility criteria, which means you should talk to your doctor about whether you qualify. This research may provide valuable insights into how maspin can influence treatment and outcomes for colorectal cancer patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • all patients with different stages of colorectal carcinoma with available paraffin blocks and clinical data .
• Exclusion Criteria:
• • all cases not fulfill the inclusion criteria .